Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.

Tissue antigens - 1 Jun 2008

Alcoceba M, Marín L, Balanzategui A, Sarasquete M E, Martín-Jiménez P, Chillón M C, Corral R, Pérez-Persona E, Fernández-Calvo F J, Hernández J M, Bladé J, Lahuerta J J, González M, San Miguel J F, García-Sanz R

Abstract excerpt

The human leukocyte antigen (HLA) system could play an essential role in multiple myeloma (MM) disease control. This report describes the results comparing HLA-DRB1 phenotypic frequencies in 181 MM patients (53 smoldering/indolent MM and 128 symptomatic MM patients) and healthy individuals. Higher DRB1*01 phenotypic frequencies were found in the smoldering patients compared with symptomatic MM patients (38% vs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to HLA-DR Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DRB1 Chains

Share to Multiple Myeloma

Share to Phenotype

Source

Identifiers

PMID: 18397187
DOI: 10.1111/j.1399-0039.2008.01048.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.PMID 18397187Read ↗

HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.Semantic proximity Read ↗

Patients with Multiple Myeloma Have Increased Co-Expression of HLA-E and HLA-DR Molecules on T-Lymphocytes and Monocytes in Peripheral BloodSemantic proximity Read ↗

Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.Semantic proximity Read ↗

Killer cell immunoglobulin-like receptors in Thai patients with multiple myeloma.Semantic proximity Read ↗

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.Semantic proximity Read ↗

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.Semantic proximity Read ↗

A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset.Semantic proximity Read ↗

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism.Semantic proximity Read ↗

Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.Semantic proximity Read ↗

Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma.Semantic proximity Read ↗

Characteristics of a Novel Target Antigen against Myeloma Cells for ImmunotherapySemantic proximity Read ↗

TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.